TheJobsMapAbout Alaya.bio
At Alaya.bio, we're developing a revolutionary targeting polymeric nanoparticle that enhances the transduction efficiency of quiescent cells such as T-cells, NK-cells, and stem cells. Our platform eliminates the need for activation factors or cytokines, resulting in reduced exhaustion of transduced cells while preserving their naive and memory phenotypes, leading to better clinical outcomes.
Founded in 2022 by Cécile BAUCHE and Renaud VAILLANT.
- Founded
- 2022
- Employees
- 11 to 50
- Total funding
- $3M
- Headquarters
- United Kingdom
Leadership
The top of Alaya.bio's org chart, with how many people report into each leader.
CB
Cécile Bauche
Founder & CSO
Jobs at Alaya.bio
No open positions right now. Explore more companies on TheJobsMap.